Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer

xloma.fota.13 shared this article with you from Inoreader Homologous recombination deficiency (HRD) score in germline <i>BRCA2</i>- versus <i>ATM</i>-altered prostate cancer Via Modern Pathology - AOP - nature.com science feeds Modern Pathology, Published online: 18 January 2021; doi:10.1038/s41379-020-00731-4 Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.